The impact of the improvement of glycometabolism in patients with type 2 diabetes on sleep disturbance including sleep disordered breathing following an admission to control their glucose metabolism.

The impact of the improvement of glycometabolism in patients with type 2 diabetes on sleep disturbance including sleep disordered breathing following an admission to control their glucose metabolism. - The impact of the improvement of glycometabolism on sleep disturbance including sleep apnea.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000045728

Enrollment

Registered

2021-10-18

Start date

2021-09-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes with sleep disturbance including sleep disordered breathing

Interventions

Acti Watch The actiwatch is a wrist watch that records physical movement and light constantly and provides us information about a patient&#39

s sleep, wake pattern, and sleep duration. Duration: From 2 to 7 days before, during hospitalization, and following 3 months of admission. Frequency:24 hours/day during each intervention. Fre

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes who are admitted to control their glucose metabolism

Exclusion criteria

Exclusion criteria: 1.Patients who were already diagnosed as sleep apnea syndrome and treated. 2.Patients with diabetes who were diagnosed as not tyoe 2 but the others. 3.Patients with diabetic ketosis or ketoacidosis 4.Patients with cancer 5.Patients taking corticosteroids. 6.Patients on oxygen therapy 7.Patients with hemodialysis 8.Patients with a cardiac pacemaker 9.Premenoposal female 10. Patients with physical activity restrictions due to disability 11.Patients who refuse to participate in this trial. 12. Patients who are judged to be inappropriate as a candidate by the doctor.

Design outcomes

Primary

Measure	Time frame
Changes in the severity of sleep disturbance such as respiratory event index, objective sleep duration, the severity of sleep disruption, and sleep latency)	—

Secondary

Measure	Time frame
Blood sugar level HOMA-IR HOMA-beta BMI Lipid metabolism ABI(Ankle - Brachial Index) PWV(PulseWave Velocity) Intima Media Thickness	—

Countries

Japan

Contacts

Public ContactMamiko Hoshi

Graduate school of medicine, Nihon university Respitory medicine

mema21005@g.nihon-u.ac.jp03-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026